fda tirzepatide injection shortage resolved oct 2 2024 US says Lilly's weight-loss drug is Eli Lilly joins FDA as

It is a novel triple agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1) , glucose-dependent insulinotropic polypeptide (GIP) , and glucagon receptors

One company has already announced that it will stop manufacturing the doses of semaglutide that are available as Wegovy, but will continue to manufacture personalized doses

In Stock Store pick-up Collect your order in-store R35 or FREE for orders over R350

The goal is to quiet the constant 'food noise' so you can focus on living a healthier, more vibrant life

Regular Exercise: Exercise isnt just good for your overall health but also for your digestion

Following the recommended storage temperaturebetween 36F and 46F (2C to 8C)helps ensure that patients receive the full benefit of this advanced treatment